CA49937-4 - 0x000000000000699F

Males & Females of Non-Childbearing Potential

Morning

* Stipend may pay up to reflected amount.
Start Date: 
March 1, 2026 - 2:45pm
End Date: 
May 11, 2026 - 10:15am

Study Details

Study Number: CA49937
Group Number: 4
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,750.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 4 Returns

Screening Dates:

Event Day Event Date
Monday 2/23/2026
Friday 2/27/2026
Saturday 2/28/2026

Doctor Exam Dates:

Event Day Event Date
Monday 2/23/2026
Friday 2/27/2026
Saturday 2/28/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 3/1/2026 2:45:00 PM Friday 3/6/2026 9:15:00 AM 1 Lincoln
Return Monday 3/16/2026 9:05:00 AM Monday 3/16/2026 10:15:00 AM 1 Lincoln
Return Monday 3/30/2026 9:05:00 AM Monday 3/30/2026 10:15:00 AM 1 Lincoln
Return Monday 4/13/2026 9:05:00 AM Monday 4/13/2026 10:15:00 AM 1 Lincoln
Return Monday 5/11/2026 9:05:00 AM Monday 5/11/2026 10:15:00 AM 1 Lincoln